share_log

Aclaris Therapeutics(ACRS.US) Director Buys US$17,955 in Common Stocks

moomoo News ·  Mar 5 17:43

$Aclaris Therapeutics (ACRS.US)$ Director Powell Andrew Kenneth William purchased 14,500 shares of Common Stocks on Mar 1, 4, 2024 at an average price of $1.24 for a total value of $17,955.

1709678607292438631.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment